Lindsay A. Rosenwald MD - 05 Aug 2025 Form 4 Insider Report for Journey Medical Corp (DERM)

Role
Director
Signature
/s/ Ramsey Alloush, attorney-in-fact
Issuer symbol
DERM
Transactions as of
05 Aug 2025
Net transactions value
$0
Form type
4
Filing time
07 Aug 2025, 17:18:06 UTC
Previous filing
07 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ROSENWALD LINDSAY A MD Director C/O JOURNEY MEDICAL CORPORATION, 9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE /s/ Ramsey Alloush, attorney-in-fact 07 Aug 2025 0000941841

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DERM Common Stock, $0.0001 par value Award $0 +50,000 +31% $0.000000 211,146 05 Aug 2025 Direct F1, F2
holding DERM Common Stock, $0.0001 par value 176,470 05 Aug 2025 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 5, 2025, the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 16,667 shares on August 5, 2028, 16,667 shares on August 5, 2029 and 16,666 shares on August 5, 2030.
F2 Includes restricted stock units, which vest over various time periods.
F3 The shares are held by a limited liability company which the reporting person, as managing member, is deemed to have voting and investment power.